Correction to: Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression.

Chen, Dong-Liang; Ju, Huai-Qiang; Lu, Yun-Xin; Chen, Le-Zong; Zeng, Zhao-Lei; Zhang, Dong-Sheng; Luo, Hui-Yan; Wang, Feng; Qiu, Miao-Zhen; Wang, De-Shen; Xu, Da-Zhi; Zhou, Zhi-Wei; Pelicano, Helene; Huang, Peng; Xie, Dan; Wang, Feng-Hua; Li, Yu-Hong; Xu, Rui-Hua

Chen, Dong-Liang; Ju, Huai-Qiang; Lu, Yun-Xin; Chen, Le-Zong; Zeng, Zhao-Lei; Zhang, Dong-Sheng; Luo, Hui-Yan; Wang, Feng; Qiu, Miao-Zhen; Wang, De-Shen; Xu, Da-Zhi; Zhou, Zhi-Wei; Pelicano, Helene; Huang, Peng; Xie, Dan; Wang, Feng-Hua; Li, Yu-Hong; Xu, Rui-Hua.

Affiliation

Chen DL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Ju HQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Lu YX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Chen LZ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Zeng ZL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Zhang DS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Luo HY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Wang F; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Qiu MZ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Wang DS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Xu DZ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Zhou ZW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Pelicano H; University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Huang P; University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Xie D; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Wang FH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Li YH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Xu RH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China. xurh@sysucc.org.cn.

J Exp Clin Cancer Res ; 40(1): 208, 2021 Jun 24.

Article de En | MEDLINE | ID: mdl-34167550

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: J Exp Clin Cancer Res Année: 2021 Type de document: Article